GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>After the EMEA debacle the future of Atryn and even GTCB's platform was teetering on the abiss. If they had not gotten a reversal who knows what might of happened and they close to being out of money then. I talked to Cox at the shareholder after the negative opinion,,,,it was a really dark time..I got the sense then of his determination that he was a good CEO for the company.<

Dr. Cox was the right CEO when GTC’s overriding goal was to have the first transgenically-produced drug approved anywhere in the world. Well done.

Now, however, the skill set needed at the top to build a successful business is rather different from what was needed in 2006.